Tenda Eric Daniel, Yulianti Mira, Asaf Moses Mazmur, Yunus Reyhan Eddy, Septiyanti Wita, Wulani Vally, Pitoyo Ceva Wicaksono, Rumende Cleopas Martin, Setiati Siti
Division of Respirology and Critical Care, Departement of Internal Medicine, Faculty of Medicine Universitas Indonesia. Dr Cipto Mangunkusumo National General Hospital. Imperial College London.
Acta Med Indones. 2020 Jan;52(1):68-73.
The coronavirus disease 2019 (COVID-19) is a highly transmissible acute respiratory disease that is caused by the Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2), a beta coronavirus first discovered in Wuhan, China, in late 2019. COVID-19 has been spreading swiftly globally, and as of March 2020, has been officially declared a pandemic by the World Health Organization (WHO). One of the challenges in managing COVID-19 is the identification of a swift, accessible, and reliable diagnostic modality that could serve as an alternative to a reverse-transcriptase polymerase chain reaction (RT-PCR). As of the writing of this paper, RT-PCR is still the recommended tool in diagnosing COVID-19, but the notion of a more prompt and accurate diagnostic tool is a possibility worth looking into. The objective of this case study is to investigate the importance and utility of chest computed tomography (CT) in the diagnosis of COVID-19, as increasing pieces of evidence suggest that chest CT could prove useful in the clinical pathway in diagnosing COVID-19.
2019冠状病毒病（COVID-19）是一种由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引起的高传染性急性呼吸道疾病，SARS-CoV-2是一种β冠状病毒，于2019年末在中国武汉首次发现。COVID-19已在全球迅速传播，截至2020年3月，世界卫生组织（WHO）已正式宣布其为大流行病。管理COVID-19的挑战之一是确定一种快速、便捷且可靠的诊断方法，可作为逆转录聚合酶链反应（RT-PCR）的替代方法。截至撰写本文时，RT-PCR仍是诊断COVID-19的推荐工具，但开发一种更快速、准确的诊断工具的想法值得探讨。本病例研究的目的是调查胸部计算机断层扫描（CT）在COVID-19诊断中的重要性和实用性，因为越来越多的证据表明胸部CT在COVID-19的临床诊断途径中可能有用。
